These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11009102)

  • 1. The synthetic, oxidized C-terminal fragment of the Plasmodium berghei circumsporozoite protein elicits a high protective response.
    Roggero MA; Meraldi V; López JA; Eberl G; Romero JC; Matile H; Betschart B; Corradin G; Renggli J
    Eur J Immunol; 2000 Sep; 30(9):2679-85. PubMed ID: 11009102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V; Romero JF; Kensil C; Corradin G
    Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule.
    Romero P; Eberl G; Casanova JL; Cordey AS; Widmann C; Luescher IF; Corradin G; Maryanski JL
    J Immunol; 1992 Mar; 148(6):1871-8. PubMed ID: 1541825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242-310 from the circumsporozoite protein of Plasmodium berghei.
    Meraldi V; Audran R; Romero JF; Brossard V; Bauer J; López JA; Corradin G
    Vaccine; 2003 Jun; 21(19-20):2485-91. PubMed ID: 12744882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides.
    Blum-Tirouvanziam U; Beghdadi-Rais C; Roggero MA; Valmori D; Bertholet S; Bron C; Fasel N; Corradin G
    J Immunol; 1994 Nov; 153(9):4134-41. PubMed ID: 7930617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED; Corradin G; Hoffman SL
    J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei.
    Weiss WR; Berzofsky JA; Houghten RA; Sedegah M; Hollindale M; Hoffman SL
    J Immunol; 1992 Sep; 149(6):2103-9. PubMed ID: 1517574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
    Tartz S; Rüssmann H; Kamanova J; Sebo P; Sturm A; Heussler V; Fleischer B; Jacobs T
    Vaccine; 2008 Nov; 26(47):5935-43. PubMed ID: 18804138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei.
    Bergmann-Leitner ES; Duncan EH; Leitner WW; Neutzner A; Savranskaya T; Angov E; Tsokos GC
    Vaccine; 2007 Nov; 25(45):7732-6. PubMed ID: 17931754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
    Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
    Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct T cell specificities are induced with the authentic versus recombinant Plasmodium berghei circumsporozoite protein.
    Krzych U; Jareed T; Link HT; Loomis LD; Ballou WR
    J Immunol; 1992 Apr; 148(8):2530-8. PubMed ID: 1348519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studies.
    Roggero MA; Weilenmann C; Bonelo A; Audran R; Renggli J; Spertini F; Corradin G; López JA
    Parassitologia; 1999 Sep; 41(1-3):421-4. PubMed ID: 10697896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of circumsporozoite protein-specific T-cells in protective immunity against Plasmodium berghei.
    Krzych U; White K; Link HT; Sadoff J; Lanar D; Ballou WR; Jareed T; Agarwal A
    Bull World Health Organ; 1990; 68 Suppl(Suppl):88-93. PubMed ID: 2094596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
    Bongfen SE; Ntsama PM; Offner S; Smith T; Felger I; Tanner M; Alonso P; Nebie I; Romero JF; Silvie O; Torgler R; Corradin G
    Vaccine; 2009 Jan; 27(2):328-35. PubMed ID: 18984024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite protein vaccines. Overcoming genetic restriction with whole organism and subunit vaccines.
    Hoffman SL; Berzofsky JA; Isenbarger D; Zeltser E; Majarian WR; Gross M; Ballou WR
    J Immunol; 1989 May; 142(10):3581-4. PubMed ID: 2497175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.